Phase 4 Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with mild to moderate Alzheimer's disease, as defined by NIA-AA guidelines.
- People who have shown a gradual decline in memory and daily functioning over at least one year.
- People whose score on the MMSE memory test falls between 11 and 24 out of 30 at the start of the trial.
- People whose score on the Hachinski Ischemic Scale (a test related to blood flow in the brain) is 4 or lower.
- People whose score on the Hamilton Depression Rating Scale (a measure of depression symptoms) is 10 or lower.
- People whose brain MRI scan results point most strongly toward Alzheimer's disease as the diagnosis.
- People who have a reliable family member, friend, or carer who can participate in the study with them.
- People willing to sign a form giving their informed consent to take part.
Who may not be able to join:
- People diagnosed with a brain or nervous system condition that causes dementia, other than Alzheimer's disease.
- People whose MRI scan shows a significant structural problem in the brain.
- People whose resting heart rate is below 50 beats per minute after resting for 10 minutes.
- People who have had a serious or unstable medical condition in the 12 months before screening.
- People who have taken donepezil, rivastigmine, galanthamine, huperzine A, memantine, or aducanumab within the 6 months before the trial starts.
- People whose liver is not functioning at an adequate level.
- People whose other major organs are not functioning at an adequate level (confirm with trial site).
- People whose ECG (heart electrical activity test) shows clinically significant abnormalities.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 21 50504988
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from baseline in the ADAS-cog/12 score; Change from baseline in ADCS-ADL23 score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.